v3.21.2
STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (27,619) $ (21,419) $ (53,995) $ (36,330)
Reconciliation of net loss to net cash used in operating activities        
Depreciation and amortization 80 47 144 95
Stock-based compensation expense     12,334 2,732
Changes in operating assets and liabilities:        
Prepaid expenses, other assets and right of use assets     (1,064) (1,137)
Accounts payable, accrued expenses, lease liabilities and other liabilities     559 7,663
Net cash used in operating activities     (42,022) (26,977)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchases of equipment and leasehold improvements     (416) (51)
Net cash used in investing activities     (416) (51)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from issuance of common stock, net of issuance costs     101,027 68,811
Purchase and cancellation of shares from BioXcel LLC       (9,024)
Exercise of stock options     1,349 310
Net cash provided by financing activities     102,376 60,097
Net increase in cash and cash equivalents     59,938 33,069
Cash and cash equivalents, beginning of the period     213,119 32,426
Cash and cash equivalents, end of the period $ 273,057 $ 65,495 273,057 65,495
Supplemental cash flow information:        
Interest paid     $ 23 $ 18

Source